EucaliaEUCALIA Inc.286A東証グロースサービス業FY ending Dec 2025, consolidated, J-GAAP
About 35% of Eucalia's sales come from Elderly care related business, with Specially-controlled medical device business and Comprehensive medical management support business making up much of the rest.
Out of every ¥100 of sales, about ¥12 is left as operating profit.
Revenue changed +9.9% from the prior year, operating profit +20.7%.
Revenue +9.9% · profit +20.7%, calculated from disclosed figures.
Operating leverage: 2.10× (profit growth ÷ revenue growth)
FY ending Dec 2023 → FY ending Dec 2024
FY ending Dec 2023 → FY ending Dec 2024
For every ¥100 Eucalia sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.